Open this publication in new window or tab >>Show others...
2012 (English)In: Acta Pathologica, Microbiologica et Immunologica Scandinavica (APMIS), ISSN 0903-4641, E-ISSN 1600-0463, Vol. 120, no 10, p. 778-785Article in journal (Refereed) Published
Abstract [en]
The aim of this study was to determine antibiotic susceptibility of Propionibacterium acnes isolates from prostate. Prostate-derived P. acnes isolates (n = 24, Umeå & Örebro, Sweden, 2007-2010) and a panel of control strains (n = 25, Sweden) collected from skin and deep infections were assessed for resistance to penicillin G, piperacillin-tazobactam, imipenem, gentamicin, azithromycin, erythromycin, vancomycin, ciprofloxacin, moxifloxacin, tetracycline, tigecycline, fusidic acid, clindamycin, rifampicin, linezolid, daptomycin, trimethoprim-sulfamethoxazole, and metronidazole. In addition, the isolates were tested for inducible clindamycin resistance. All prostate derived P. acnes isolates displayed wild-type distribution of MIC-values, without evidence of acquired resistance. In the reference panel, 5 of 25 isolates had acquired macrolide resistance with cross-resistance to azithromycin, clindamycin, and erythromycin. In addition, one of these isolates was resistant to tetracycline.
Place, publisher, year, edition, pages
HOBOKEN, NJ USA: Wiley-Blackwell, 2012
Keywords
CHRONIC BACTERIAL PROSTATITIS, RANDOMIZED CONTROLLED-TRIAL, STERNAL WOUND INFECTIONS, PELVIC PAIN SYNDROME, CARDIAC-SURGERY, ANTIMICROBIAL RESISTANCE, CLINICAL PRESENTATION, TRACT-INFECTIONS, VULGARIS, MANAGEMENT
National Category
Medical and Health Sciences
Identifiers
urn:nbn:se:umu:diva-59682 (URN)10.1111/j.1600-0463.2012.02905.x (DOI)22958285 (PubMedID)2-s2.0-84866150414 (Scopus ID)
2012-09-242012-09-242023-03-23Bibliographically approved